Generic Name and Formulations:
Butenafine HCl 1%; crm.
Indications for MENTAX:
Tinea versicolor, t. corporis, t. cruris, and interdigital t. pedis.
Apply to affected and immediately surrounding area. T. versicolor, corporis, cruris: Apply once daily for 2 wks. T. pedis: Apply twice daily for 1 wk, or once daily for 4 wks. Reevaluate if no improvement after therapy.
Avoid eyes, nose, mouth, mucous membranes. Do not occlude. Discontinue if irritation develops and confirm diagnosis. Sensitivity to allylamines. Pregnancy (Cat.B). Nursing mothers.
Burning/stinging, worsening of condition, other local irritation.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age